Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bone Marker Changes In One Month Treatment With TERIPARATIDE (LY333334) Injections (rDNA Origin) in Men and Postmenopausal Women With Severe Osteoporosis

NCT00532545 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00532545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00532545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bone Marker Changes In One Month Treatment With TERIPARATIDE (LY333334) Injections (rDNA Origin) in Men and Postmenopausal Women With Severe Osteoporosis
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2003
Completion date
April 30, 2004
Enrollment
45 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, post-menopausal